Pakistan Drug Authority Mulls Review Of All 700 Drug-Maker Licenses
This article was originally published in PharmAsia News
Executive Summary
Pakistan drug regulators are considering an industry-wide review of licenses granted to 700 drug companies over the past 20 years.